tiprankstipranks
Trending News
More News >
IDEX Corporation (IEX)
NYSE:IEX

IDEX (IEX) AI Stock Analysis

Compare
332 Followers

Top Page

IE

IDEX

(NYSE:IEX)

Rating:69Neutral
Price Target:
$195.00
â–²(9.66%Upside)
IDEX's overall score reflects strong financial health and positive earnings call highlights. However, challenges in valuation and technical indicators, along with tariff impacts, moderate enthusiasm.
Positive Factors
Earnings
The company reported a 4Q adjusted EPS of $2.04, which beat both the analyst's expectation and the consensus estimate.
Financial Performance
Adjusted EBITDA margins increased to 26.4% from the prior 25.8%, with FMT and HST contributing positively to the margin expansion.
Future Guidance
Management expects a material ramp in EBITDA margins based on improving volumes and internal cost-out initiatives.
Negative Factors
Industry Challenges
Continued weakness is anticipated in the energy and agriculture sectors, which may temper stability in core industrial markets.
Investor Sentiment
Investor confidence is low due to the substantial ramp required from weak 1Q.
Outlook
The 2025 outlook is below initial expectations, and a low first quarter guide suggests a cautious approach for the year.

IDEX (IEX) vs. SPDR S&P 500 ETF (SPY)

IDEX Business Overview & Revenue Model

Company DescriptionIDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as offers flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries. The HST segment designs, produces, and distributes precision fluidics, rotary lobe pumps, centrifugal and positive displacement pumps, roll compaction and drying systems, pneumatic components and sealing solutions, high performance molded and extruded sealing components, custom mechanical and shaft seals, engineered hygienic mixers and valves, biocompatible medical devices and implantables, air compressors and blowers, optical components and coatings, laboratory and commercial equipment, precision photonic solutions, and precision gear and peristaltic pump technologies. This segment serves food and beverage, pharmaceutical and biopharmaceutical, cosmetics, marine, chemical, wastewater and water treatment, life sciences, research, and defense markets. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, rescue tools, lifting bags, and other components and systems for the fire and rescue industry; engineered stainless steel banding and clamping devices for various industrial and commercial applications; and precision equipment for dispensing, metering, and mixing colorants and paints used in retail and commercial businesses. IDEX Corporation was incorporated in 1987 and is headquartered in Northbrook, Illinois.
How the Company Makes MoneyIDEX generates revenue primarily through transaction fees charged on trades executed on its decentralized exchange platform. These fees are typically a small percentage of the total transaction value, providing the company with a steady stream of income as trading volumes increase. Additionally, IDEX may engage in partnerships with other blockchain projects and service providers, further enhancing its revenue potential. The company's focus on maintaining a robust and efficient trading platform contributes significantly to its earnings, as it attracts more traders seeking trustworthy and cost-effective trading solutions.

IDEX Earnings Call Summary

Earnings Call Date:May 01, 2025
(Q1-2025)
|
% Change Since: 2.60%|
Next Earnings Date:Jul 29, 2025
Earnings Call Sentiment Neutral
IDEX Corporation reported a strong first quarter with revenue and profitability exceeding expectations and strategic growth platforms performing well. However, challenges such as tariff impacts, organic sales decline, and semiconductor headwinds present potential risks. Overall, the company demonstrates resilience with proactive cost-saving measures and strategic market positioning.
Q1-2025 Updates
Positive Updates
Better-than-Expected Results
IDEX delivered better-than-expected results in the first quarter of 2025, with revenue and profitability slightly above plan in each business segment, and orders increased to record levels.
Strategic Growth Platforms
IDEX is focusing on five strategic growth platforms with strong market positioning in space, defense, energy transition, municipal water, and North American Fire & Safety.
Cost Savings Initiatives
IDEX has identified an additional $20 million in savings targets for 2025, supporting a cumulative $80 million in savings, enhancing financial resilience.
Strong Performance in Fire & Safety
Fire & Safety business reported a 5% increase in organic sales and a 2% increase in organic orders, benefiting from strong OEM demand and integrated solutions.
Mott Acquisition Success
Mott, IDEX's latest acquisition, secured a $40 million multiyear agreement for a custom wastewater filtration solution, with significant future revenue potential.
Negative Updates
Organic Sales Decline
Organic sales declined by 1% in the first quarter due to challenges in the semiconductor, agriculture, chemical, and energy businesses.
Tariff Impact
Tariffs are expected to drive a $100 million annualized impact, adding 5% to 6% inflation to cost of goods sold, with two-thirds of this impact expected in 2025.
Volume Deleverage
Adjusted EBITDA margin declined by 50 basis points to 25.5% due to year-over-year volume deleverage and near-term margin dilution from the Mott acquisition.
Semiconductor Industry Headwinds
IDEX continues to face headwinds in semiconductor businesses, particularly in solutions supporting wafer fabrication, with recovery pushed out.
Company Guidance
During IDEX Corporation's first quarter 2025 earnings call, the company provided an optimistic outlook with several notable metrics. The company reported a better-than-expected performance with revenue and profitability slightly exceeding plans across all segments. For the quarter, organic sales saw a 1% decline due to difficulties in semiconductor, agriculture, chemical, and energy sectors, but orders increased by 1%, bolstering a $60 million backlog. Despite these sector challenges, IDEX maintained its full-year organic growth guidance of 1% to 3% and adjusted earnings per share (EPS) of $8.10 to $8.45, buoyed by robust demand in space, defense, and municipal water markets. The company also identified an additional $20 million in cost savings for 2025, bringing the total to $80 million, to counteract potential headwinds including tariffs, expected to add 5% to 6% in cost inflation. For the second quarter, IDEX projects organic revenue growth between flat to 2% and adjusted EPS ranging from $1.95 to $2.05.

IDEX Financial Statement Overview

Summary
IDEX demonstrates strong financial performance with robust profitability and low leverage. The income statement reflects solid profit margins, although operational efficiency has slightly declined. The balance sheet is stable with low debt, and cash flow management is efficient despite a minor decrease in free cash flow.
Income Statement
81
Very Positive
IDEX has shown solid performance in the TTM with a slight revenue increase of 0.42% from last year. The gross profit margin is strong at 44.35%, and the net profit margin is healthy at 14.60%. However, the EBIT margin has slightly decreased to 20.16%, and the EBITDA margin stands at 24.27%, indicating stable profitability but a slight decline in operational efficiency.
Balance Sheet
77
Positive
The balance sheet reflects a strong financial position with a low debt-to-equity ratio of 0.03, suggesting low leverage and reduced financial risk. The equity ratio is robust at 57.49%, indicating financial stability. However, the return on equity is moderate at 12.26%, suggesting room for improvement in generating returns for shareholders.
Cash Flow
75
Positive
IDEX's cash flow is stable with an operating cash flow to net income ratio of 1.29, indicating strong cash generation relative to income. However, the free cash flow decreased slightly by 7.49% from the previous year, and the free cash flow to net income ratio is 1.16, showing efficient cash flow management despite the decline.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
3.28B3.27B3.27B3.18B2.76B2.35B
Gross Profit
1.46B1.45B1.45B1.43B1.22B1.03B
EBIT
661.80M677.20M732.50M751.40M637.00M520.71M
EBITDA
796.70M859.40M964.10M909.80M720.50M604.60M
Net Income Common Stockholders
479.10M505.00M596.10M586.90M449.40M377.80M
Balance SheetCash, Cash Equivalents and Short-Term Investments
594.10M620.80M534.30M430.20M855.40M1.03B
Total Assets
6.80B6.75B5.87B5.51B4.92B4.41B
Total Debt
1.97B1.96B1.45B1.49B1.19B1.04B
Net Debt
1.37B1.34B911.50M1.06B334.90M18.59M
Total Liabilities
2.89B2.95B2.32B2.47B2.11B1.87B
Stockholders Equity
3.91B3.79B3.54B3.04B2.80B2.54B
Cash FlowFree Cash Flow
557.80M603.00M626.80M489.40M492.60M517.73M
Operating Cash Flow
617.20M668.10M716.70M557.40M565.30M569.27M
Investing Cash Flow
-996.50M-1.01B-283.80M-917.20M-698.10M-172.58M
Financing Cash Flow
373.60M465.90M-344.70M-37.80M-9.50M-42.60M

IDEX Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price177.82
Price Trends
50DMA
177.14
Positive
100DMA
186.29
Negative
200DMA
199.48
Negative
Market Momentum
MACD
0.71
Positive
RSI
51.51
Neutral
STOCH
75.38
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IEX, the sentiment is Neutral. The current price of 177.82 is below the 20-day moving average (MA) of 183.26, above the 50-day MA of 177.14, and below the 200-day MA of 199.48, indicating a neutral trend. The MACD of 0.71 indicates Positive momentum. The RSI at 51.51 is Neutral, neither overbought nor oversold. The STOCH value of 75.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IEX.

IDEX Risk Analysis

IDEX disclosed 17 risk factors in its most recent earnings report. IDEX reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

IDEX Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
ITITT
82
Outperform
$11.97B23.9419.27%0.93%6.99%23.25%
PNPNR
78
Outperform
$16.27B24.9218.59%1.01%-0.42%3.23%
78
Outperform
$12.32B27.5715.54%1.43%1.98%-7.66%
GGGGG
75
Outperform
$14.23B29.4820.28%1.32%-0.40%-2.50%
AOAOS
70
Outperform
$9.07B17.8527.97%2.13%-1.60%-7.12%
IEIEX
69
Neutral
$13.43B28.1612.73%1.60%1.66%-17.18%
66
Neutral
$4.47B12.225.40%3.65%4.14%-12.00%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IEX
IDEX
177.82
-19.76
-10.00%
GGG
Graco
83.54
4.44
5.61%
ITT
ITT
150.46
23.21
18.24%
NDSN
Nordson
214.36
-15.28
-6.65%
PNR
Pentair
96.62
19.43
25.17%
AOS
A. O. Smith Corporation
63.81
-18.35
-22.33%

IDEX Corporate Events

Executive/Board Changes
IDEX Announces CFO Resignation and Interim Appointment
Neutral
May 21, 2025

IDEX Corporation announced the resignation of its Senior Vice President and Chief Financial Officer, Abhishek Khandelwal, effective May 30, 2025. The company has appointed Akhil Mahendra as the interim CFO, who has been with IDEX for two years and previously worked at Rivian Automotive and Morgan Stanley. This transition is not due to any disagreements within the company, and an external search firm has been engaged to find a permanent replacement. The board has approved a restricted stock award for Mahendra, which will vest after three years, contingent on his continued service.

The most recent analyst rating on (IEX) stock is a Hold with a $220.00 price target. To see the full list of analyst forecasts on IDEX stock, see the IEX Stock Forecast page.

Executive/Board ChangesShareholder Meetings
IDEX Elects Directors at Annual Stockholder Meeting
Neutral
May 12, 2025

On May 8, 2025, IDEX Corporation held its Annual Meeting of Stockholders where key decisions were made. Three Class III directors, Eric D. Ashleman, Stephanie J. Disher, and Matthijs Glastra, were elected for a three-year term. Additionally, the compensation of named executive officers was approved, and Deloitte & Touche LLP was ratified as the independent public accounting firm for 2025. However, a stockholder proposal for a report on hiring practices related to individuals with arrest or incarceration records did not pass.

The most recent analyst rating on (IEX) stock is a Hold with a $220.00 price target. To see the full list of analyst forecasts on IDEX stock, see the IEX Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.